COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,695 Articles (22,913 medRxiv, 8,782 bioRxiv)

Most recent first Previous |  Page 194: Articles 1931-1940  | Next

Oxytocin-mediated social preference and socially reinforced reward learning in the miniature fish Danionella cerebrum
Penalva, A., Bedke, J., Gaudin, A., Barrios, J. P., Bertram, E. P. L., Douglass, A. D.
10.1101/444026 — Posted: 2024-10-22
Evaluation of post-acute COVID-19 health outcomes (ECHOES) in England: The development of national surveillance system for long- term health outcomes following COVID-19
Allen, H., Hassell, K., Rawlinson, C., Pullen, O., Campbell, C., Jodicke, A. M., Catala, M., Prats-Uribe, A., Dabrera, G., Prieto-Alhambra, D., Campos-Matos, I.
10.1101/2024.10.18.24315744 — Posted: 2024-10-21
Incident COVID-19 infections before Omicron in the US
Lobay, R., Srivastava, A., Tibshirani, R. J., McDonald, D. J.
10.1101/2024.10.18.24315777 — Posted: 2024-10-21
Statistical relationship between wastewater data and case notifications for COVID-19 surveillance in the United States, 2020-2023: a Bayesian hierarchical model.
Haraguchi, M., Klaassen, F., Cohen, T., Salomon, J. A., Menzies, N. A.
10.1101/2024.10.20.24315840 — Posted: 2024-10-21
This is SPRTA: assessing phylogenetic confidence at pandemic scales
De Maio, N., Ly-Trong, N., Minh, B. Q., Goldman, N.
10.1101/2024.10.21.619398 — Posted: 2024-10-21
Integrative Transcriptomic Profiling of NK Cells and Monocytes: Advancing Diagnostic and Therapeutic Strategies for COVID-19.
Loukman, S., BENMRID, R., BOUCHMAA, N., HBOUB, H., EL FATIMY, R., Benhida, R.
10.1101/2024.10.21.619361 — Posted: 2024-10-21
P3 site-directed mutagenesis: An efficient method based on primer pairs with 3-prime overhangs
Mousavi, N., Zhou, E., Razavi, A., Ebrahimi, E., Varela-Castillo, P., Yang, X.-J.
10.1101/2024.10.18.615663 — Posted: 2024-10-21
Salivary IgG antibody response against SARS-CoV-2 differs between vaccinated children and adults
Badano, M. N., Keitelman, I., Pereson, M. J., Aloisi, N., Sabbione, F., Bare, P.
10.1101/2024.10.18.24315700 — Posted: 2024-10-19
Intrahost dynamics, together with genetic and phenotypic effects predict the success of viral mutations
Tan, C. C. S., Escalera-Zamudio, M., Yavlinsky, A., van Dorp, L.
10.1101/2024.10.18.619070 — Posted: 2024-10-19
Nirmatrelvir-Resistant Mutations in SARS-CoV-2 Mpro Enhance Host Immune Evasion via Cleavage of NF-κB Essential Modulator
Thomas, M., Hughes, T.
10.1101/2024.10.18.619137 — Posted: 2024-10-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).